@1IDCNMI ลองหาดู ใช่อันที่กล่าวใน review นี้หรือเปล่านะครับ n= 24 คนเอง 😅 https://t.co/5orUHykmrM
@fluidloading @sudokuvariante @XavierBazin2 2/2 "Les infections nosocomiales constituaient le principal "effet secondaire" lié à la corticothérapie rapporté dans les études incluses ; la plupart des études ont rapporté un risque accru d'infection nosocomia
@caz_sampson @jim_reed @VaccineMole https://t.co/QdnooAnHO8 corticosteroids for covid https://t.co/kO9uPRlZUw corticosteroids for flu
@FGarridoB @Papodavo @hbcabrerag @OmarVilaCampill Puede leer más y sigue controvertido. Se requiere más evidencia. Se ha visto beneficio en enfermedad severa. https://t.co/5edxKOQHIC
@b0rza @_DoK_ToR_ @vaju01 @LadaElena42 @tass_agency Асвторы статьи там приведены. Там не только витамин Д, там вообще результаты лечения микроэлементами. На сегодняшний день другого эффективного лечения не существует. https://t.co/u8dVWvk3yk https://t.co/
3/ Background: COVID19 can induce a deadly hyper-inflammatory host response. Prior observational data (↓quality, ↑risk of confounding by indication) suggested ↑mortality from steroids in influenza: https://t.co/nX7gyDddCp The role of steroids in treating
De diskuterar även hur vissa tidigare resultat av kortikosteroiders effekt – vid #COVID19-liknande virala tillstånd – ev. pga tajming & dos– har varit inkonklusiva eller gett negativa utfall (t.ex. vid SARS-CoV-1 & influensa: https://t.co/bJquXHn1z
@rgbMDPhD @boback @hawkdawk Information such as in this Cochrane Systematic Review -Corticosteroids as adjunctive therapy in the treatment of influenza https://t.co/vF9V5s864Z
RT @hawkdawk: @peakpilot @PaulSaxMD @AbraarKaran @MartinLandray @PeterHorby In studies of influenza therapies, corticosteroid treatment ben…
@peakpilot @PaulSaxMD @AbraarKaran @MartinLandray @PeterHorby In studies of influenza therapies, corticosteroid treatment benefit is lacking with substantial evidence to implicate harm. Likelihood of harm from corticosteroid was most evident when indicated
The important point: Before #covid19 it was unclear whether risks outweigh benefits. A Cochrane Review first published in 2016 found that treating H1N1 patients with corticosteroids was associated with a higher risk of dying. https://t.co/dOXX8xPhT4
RT @NottmBRCLung: Corticosteroids as adjunctive therapy in the treatment of influenza - Lansbury, L - 2019 | Cochrane Library https://t.co/…
Corticosteroids as adjunctive therapy in the treatment of influenza - Lansbury, L - 2019 | Cochrane Library https://t.co/KJZOG3nSmS @nuhresearch @NottmBRC
Is there a connection between adjunctive corticosteroids and increased mortality in patients with influenza? Check out this Cochrane review of the literature to learn more. https://t.co/wYh7K3zBhR
Corticosteroids as adjunctive therapy in the treatment of influenza - Lansbury, L - 2019 | Cochrane Library https://t.co/Ej6iatA9yg
@cristinartcosta Obrigado pelo alerta! Cá vai o correcto https://t.co/wQuO7HHnXZ